Revelation Biosciences Inc (NASDAQ:REVB)’s traded shares stood at 0.69 million during the latest session, with the company’s beta value hitting 0.22. At the last check today, the stock’s price was $1.22, to imply a decrease of -2.40% or -$0.03 in intraday trading. The REVB share’s 52-week high remains $28.20, putting it -2211.48% down since that peak but still an impressive 33.61% since price per share fell to its 52-week low of $0.81. The company has a valuation of $2.00M, with an average of 9.28 million shares in intraday trading volume over the past 10 days and average of 2.11 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Revelation Biosciences Inc (REVB), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give REVB a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -3.16.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Revelation Biosciences Inc (NASDAQ:REVB) trade information
After registering a -2.40% downside in the latest session, Revelation Biosciences Inc (REVB) has traded red over the past five days. The 5-day price performance for the stock is 41.70%, and -24.69% over 30 days. With these gigs, the year-to-date price performance is -91.88%. Short interest in Revelation Biosciences Inc (NASDAQ:REVB) saw shorts transact 42054.0 shares and set a 0.39 days time to cover.
Revelation Biosciences Inc (REVB) estimates and forecasts
Looking at statistics comparing Revelation Biosciences Inc share performance against respective industry, we note that the company has outperformed competitors. Revelation Biosciences Inc (REVB) shares are -56.43% down over the last 6 months, with its year-to-date growth rate higher than industry average at 66.29% against 18.60%. Revenue is forecast to grow 74.90% this quarter before jumping 70.90% for the next one.
REVB Dividends
Revelation Biosciences Inc has its next earnings report out on 2024-Nov-07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders
Revelation Biosciences Inc insiders hold 0.32% of total outstanding shares, with institutional holders owning 3.12% of the shares at 3.13% float percentage. In total, 3.12% institutions holds shares in the company.
